Showing results (321-330 of 443) with videos related to

Sort By:
Pageof 45
BMC Pulmonary Medicine|November 26, 2011
Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatmentPersijn J Honkoop, Rik J B Loymans, Evelien H Termeer, et al.
American Journal of Respiratory and Critical Care Medicine|November 23, 2021
Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe AsthmaAngelica Tiotiu, Yusef Badi, Nazanin Zounemat Kermani, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2008
Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthmaAnnelies M Slats, Kirsten Janssen, Annemarie van Schadewijk, et al.
The European Respiratory Journal|February 10, 2017
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
American Journal of Respiratory and Critical Care Medicine|March 24, 2007
Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary diseaseAnnelies M Slats, Kirsten Janssen, Annemarie van Schadewijk, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 11, 2019
Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptomsAbilash Ravi, Meiping Chang, Marianne van de Pol, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 7, 2016
Prevalence of rhinoviruses in young children of an unselected birth cohort from the NetherlandsJ G Wildenbeest, M P van der Schee, S Hashimoto, et al.
Plos One|December 15, 2015
Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled TrialJiska B Snoeck-Stroband, Therese S Lapperre, Peter J Sterk, et al.
Pageof 45